Cargando…

Bladder tuberculosis with ureteral strictures after bacillus Calmette‑Guérin therapy for urinary bladder cancer: A case report

Intravesical immunotherapy using bacillus Calmette-Guérin (BCG) is recommended for patients with intermediate- to high-risk non-muscle invasive bladder cancer. Bladder tuberculosis (TB) is a rare complication of BCG therapy. The present study describes the case of a 73-year-old man who underwent int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tominaga, Yusuke, Fujii, Masanori, Sadahira, Takuya, Katayama, Satoshi, Iwata, Takehiro, Nishimura, Shingo, Bekku, Kensuke, Edamura, Kohei, Kobayashi, Tomoko, Kobayashi, Yasuyuki, Kiura, Katsuyuki, Maeda, Yoshinobu, Wada, Koichiro, Araki, Motoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886853/ https://www.ncbi.nlm.nih.gov/pubmed/36761388 http://dx.doi.org/10.3892/mco.2022.2603

Ejemplares similares

A Novel Technique Using Fluorescent Ureteral Catheter and Flexible Ureteroscope for Safe Laparoscopic Fenestration of Lymphocele after Kidney Transplantation
por: Sekito, Takanori, et al.
Publicado: (2022)

Bacillus Calmette-Guérin in the management of superficial bladder cancer
por: Kapoor, Rakesh, et al.
Publicado: (2008)

Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update
por: Guallar-Garrido, Sandra, et al.
Publicado: (2020)

Bacillus Calmette-Guérin (BCG) Brazilian Backstage in Bladder Cancer
Publicado: (2021)

Feasibility of robot‑assisted radical cystectomy in a patient with an ectopic kidney: A case report
por: Edamura, Kohei, et al.
Publicado: (2022)

Predictive biomarkers of response to bacillus Calmette‐Guérin immunotherapy and bacillus Calmette‐Guérin failure for non‐muscle invasive bladder cancer
por: Wang, Ziting, et al.
Publicado: (2022)

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
por: Saban, Marcia R, et al.
Publicado: (2007)

Intravesical bacillus Calmette-Guérin for bladder cancer: are all the strains equal?
por: D’Andrea, David, et al.
Publicado: (2019)

Pleural Effusion Caused by Bacillus Calmette-Guérin Immunotherapy for Bladder Cancer
por: Rachakonda, Tara, et al.
Publicado: (2017)

Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer
por: Miyazaki, Masashi, et al.
Publicado: (2016)

A case of tape infection 19 years after insertion of a tension‐free vaginal tape sling
por: Watanabe, Tomofumi, et al.
Publicado: (2022)

Systemic Granulomatous Reaction Secondary to Treatment of Bladder Cancer with Bacillus Calmette-Guerin
por: Valentini, Caterina Giovanna, et al.
Publicado: (2012)

Guillain Barré syndrome associated with bladder instillation of Bacille Calmette Guérin (BCG)
por: Webb, Karmel, et al.
Publicado: (2018)

Spinal Tuberculosis Secondary to Intravesical Bacille Calmette-Guerin Treatment for Bladder Cancer
por: Yergin, Celeste G, et al.
Publicado: (2021)

Combination of Intravesical Bacille Calmette-Guérin and Chemotherapy vs. Bacille Calmette-Guérin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis
por: Huang, Di, et al.
Publicado: (2019)

Impact of intravesical Bacillus Calmette-Guérin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer
por: James, Christopher, et al.
Publicado: (2023)

Evaluation of the Dwell-Time and Dose Difference in Intravesical Bacillus Calmette-Guèrin Therapy
por: Nagai, Takashi, et al.
Publicado: (2019)

Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin
por: Soylu, Aliye, et al.
Publicado: (2009)

Intravesical bacillus Calmette-Guerin for bladder cancer: What is known? What is not? What is next?
por: Madbouly, Khaled
Publicado: (2013)

Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guérin for Bladder Cancer
por: Liu, Yuqing, et al.
Publicado: (2019)

Efficacy and safety of Bacillus Calmette-Guerin for bladder cancer: A protocol of systematic review
por: Zhang, Zhi-hui, et al.
Publicado: (2020)

Role of immunotherapy in Bacillus Calmette-Guérin unresponsive: non-muscle invasive bladder cancer
por: Suh, Jungyo, et al.
Publicado: (2020)

Emerging treatments for bacillus Calmette–Guérin-unresponsive non-muscle-invasive bladder cancer
por: Kim, Hyung Suk, et al.
Publicado: (2021)

Treatment strategies for the Bacillus Calmette-Guérin–unresponsive non-muscle invasive bladder cancer
por: Jeong, Seung-hwan, et al.
Publicado: (2023)

Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing.
por: Pryor, K., et al.
Publicado: (1995)

Mycobacterium bovis Bacillus Calmette-Guérin-Induced Macrophage Cytotoxicity against Bladder Cancer Cells
por: Luo, Yi, et al.
Publicado: (2010)

Bilateral symmetrical corneal melting following intravesical Bacille Calmette-Guerin therapy for bladder carcinoma
por: Chakraborty, Chandana, et al.
Publicado: (2012)

Predictive Biomarkers of Bacillus Calmette-Guérin Immunotherapy Response in Bladder Cancer: Where Are We Now?
por: Lima, Luís, et al.
Publicado: (2012)

Bladder Contracture – A Rare and Serious Side Effect of Intravesical Bacillus Calmette-Guérin Therapy
por: Garcia, Cindy, et al.
Publicado: (2015)

Targeting estrogen/estrogen receptor alpha enhances Bacillus Calmette-Guérin efficacy in bladder cancer
por: Shang, Zhiqun, et al.
Publicado: (2016)

T1G3 bladder cancer, bacillus Calmette-Guerin and radical cystectomy: continued debate
por: Brodie, Andrew, et al.
Publicado: (2018)

Renal Tuberculosis Following Intravesical Bacillus Calmette–Guérin (BCG) Immunotherapy for the Treatment of Bladder Cancer
por: Bajramovic, Senad, et al.
Publicado: (2020)

Bacillus Calmette-Guérin (BCG) therapy lowers the incidence of Alzheimer’s disease in bladder cancer patients
por: Gofrit, Ofer N., et al.
Publicado: (2019)

Granulomatous Hepatitis Following Intra-Vesical Instillation of Bacillus Calmette–Guérin for Treatment of Bladder Cancer
por: Branco, Elsa Alves, et al.
Publicado: (2021)

A Case of Systemic Toxicity Related to Intravesical Bacillus Calmette-Guerin for the Treatment of Bladder Cancer
por: Gupta, Sachin, et al.
Publicado: (2021)

Bacillus Calmette–Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer
por: Su, Fei, et al.
Publicado: (2022)

Immunotherapy With Bacillus Calmette-Guerin (BCG) in a 16-Year-Old With Urothelial Bladder Carcinoma
por: Martinez-Thomas, Jose M, et al.
Publicado: (2022)

FGFBP1 as a potential biomarker predicting bacillus Calmette–Guérin response in bladder cancer
por: Li, Fei, et al.
Publicado: (2022)

Replacement Instead of Discontinuation of Bacillus Calmette-Guérin Instillation in Non-Muscle-Invasive Bladder Cancer
por: Lin, Po-Ting, et al.
Publicado: (2023)

Fluorescence in situ hybridization (FISH) to predict the efficacy of Bacillus Calmette-Guérin perfusion in bladder cancer
por: Ke, Chunjin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m7hl0mjq6if48f4r1tjb1o9fgf